Impaired Proliferation and Differentiation of Myelodysplastic CD34⁺ Cells

References

• Saarni M. I., Linman J. W. Preleukemia: The hematologic syndrome preceding acute leukemia. Am. J. Med. 1973; 55: 38–48
   PubMed Web of Science ®Google Scholar
• Greenberg P. L., Mara B. The preleukemic syndrome. Correlation of in vitro parameters of granulopoiesis with clinical features. Am. J. Med. 1979; 66: 951–958
   PubMed Web of Science ®Google Scholar
• Koeffler H. P., Golde D. W. Human preleukemia. Ann. Intern. Med. 1980; 93: 347–353
   PubMed Web of Science ®Google Scholar
• Linman J. W., Bagby G. C. The smoldering myeloid leukemic states. Clinical and biologic features. Blood 1983; 61: 1035–1044
   PubMed Web of Science ®Google Scholar
• Greenberg P. L. The smoldering myeloid leukemic states. Clinical and biologic features. Blood 1983; 61: 1035–1044
   PubMed Web of Science ®Google Scholar
• Prchal J. T., Throckmorton D. W., Carroll A. J., Fuson E. W., Gams R. A., Prchal J. S. A common progenitor for human myeloid and lymphoid cells. Nature 1978; 274: 590–591
   PubMed Web of Science ®Google Scholar
• Abkowitz J. L., Fialkow P. J., Niebruge D. J., Raskind W. H., Adamson J. W. Pancytopenia as a clonal disorder of a multipotent hemopoietic stem cell. J. Clin. Invest. 1984; 73: 258–261
   PubMed Web of Science ®Google Scholar
• Raskind W. H., Tirumali N., Jacobsen R., Singer J., Fialkow P. J. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 1984; 63: 1318–1323
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Nathan D. G., Chess L., Hillman D. G., Clarke B., Breard J., Merler E., Housman D. E. Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro. J. Exp. Med. 1978; 147: 324–339
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Lin N., Adamson J. W. Interleukin 1 stimulates fibroblasts to synthesize granulocytemacrophage and granulocyte colony-stimulating factors. J. Clin. Invest. 1988; 81: 92–97
   PubMed Web of Science ®Google Scholar
• Ohmori M., Ohmori S., Ueda Y., Tohyama K., Yoshida Y., Uchino H. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haematopoietic progenitor cells. Br. J. Haematol. 1990; 74: 179–184
   PubMed Web of Science ®Google Scholar
• Michalevicz M., Porat R., Vechoropoulos M., Baron S., Yanoov M., Cycowitz Z., Shibolet S. Restoration of in vitro hematopoiesis in B-chronic lymphocytic leukemia by antibodies to tumor necrosis factor. Leukemia Res. 1991; 15: 111–120
   PubMed Web of Science ®Google Scholar
• Sawada K., Sato N., Tarumi T., Sakai N., Koizumi K., Sakurama S., Leko M., Yasukouchi T., Koyanagawa Y., Yamaguchi M., Ohmoto A., Kohno M., Koike T. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: response to individual colony-stimulating factors. Br. J. Haematol. 1993; 83: 249–358
   Web of Science ®Google Scholar
• Sawada K., Krantz S. B., Dessypris E. N., Koury S. T., Sawyer S. T. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J. Clin. Invest. 1989; 83: 1701–1709
   PubMed Web of Science ®Google Scholar
• Civin C. I., Strauss L. C., Brovall C., Fackler M. J., Schwartz J. F., Shaper J. H. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J. Immunol. 1984; 133: 157–165
   PubMed Web of Science ®Google Scholar
• Strauss L. C., Rowley S. D., La Russa V. F., Sharkis S. J., Stuart R. K., Civin C. I. Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp. Hematol. 1986; 14: 878–886
   PubMed Web of Science ®Google Scholar
• Civin C. I., Banquerigo M. L., Strauss L. C., Loken M. R. Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp. Hematol. 1987; 15: 10–17
   PubMed Web of Science ®Google Scholar
• Loken M. R., Shah V. O., Dattilio K. L., Civin C. I. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987; 70: 1316–1324
   PubMed Web of Science ®Google Scholar
• Ryan D., Kossover S., Mitchell S., Frantz C., Hennessy L., Cohen H. Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood 1986; 68: 417–425
   PubMed Web of Science ®Google Scholar
• Leary A. G., Ogawa M., Strauss L. C., Civin C. I. Single cell origin of multilineage colonies in culture: evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic process. J. Clin. Invest. 1984; 74: 2193–2197
   PubMed Web of Science ®Google Scholar
• Schmitt C., Eaves C. J., Lansdorp P. M. Expression of CD34 on human B cell precursors. Clin. Exp. Immunol. 1991; 85: 168–173
   PubMed Web of Science ®Google Scholar
• Tindle R. W., Nichols R. A. B., Chan L. C., Campana D., Birnie G. A novel monoclonal antibody BI.3C5 recognizes myeloblasts and non B., non T lymphoblasts in acute leukemias and CGL blast crisis and reacts with immature cells in normal bone marrow. Leukemia Res. 1984; 9: 1–9
   Web of Science ®Google Scholar
• Civin C. I. Human monomyeloid cell membrane antigens. Exp. Hematol. 1990; 18: 461–467
   PubMed Web of Science ®Google Scholar
• Terstappen L. W. M. M., Huang S., Safford M., Lansdorp P. M., Loken M. R. Sequential generations of hematopoietic colonies derived from single nonlineagecommitted CD34+CD38− progenitor cells. Blood 1991; 77: 1218–1227
   PubMed Web of Science ®Google Scholar
• Verfaillie C., Blakolmer K., McGlave P. Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. J. Exp. Med. 1990; 172: 509–520
   PubMed Web of Science ®Google Scholar
• Brandt J., Srour E. F., van Besien K., Briddell R. A., Hoffman R. Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J. Clin. Invest. 1990; 86: 932–941
   PubMed Web of Science ®Google Scholar
• Bender J. G., Unverzagt K. L., Walker D. E., Lee W., Van Epps D. E., Smith D. H., Stewart C. C., To L. B. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 1991; 77: 2591–2596
   PubMed Web of Science ®Google Scholar
• Egeland T., Steen R., Quarsten H., Gaudernack G., Yang Yu.-C., Thorsby E. Myeloid differentiation of purified CD34 cells after stimulation with recombinant human granulocyte-monocyte colony-stimulating factor (CSF), granulocyte-CSF, monocyte-CSF, and interleukin-3. Blood 1991; 78: 3192–3199
   PubMed Web of Science ®Google Scholar
• Lu L., Walker D., Broxmeyer H. E., Hoffman R., Hu W., Walker E. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My 10 and major histocompatibility class II monoclonal antibodies. J. Immunol. 1987; 139: 1823–1829
   PubMed Web of Science ®Google Scholar
• Buhring H. J., Asenbauer B., Katrilaka K., Hummel G., Busch F. W. sequential expression of CD34 and CD33 antigens on myeloid colony-forming cells. Eur. J. Hematol. 1989; 42: 143–149
   PubMed Web of Science ®Google Scholar
• Siena S., Bregni M., Brando B., Belli N., Ravagnani F., Gandola L., Stern A. C., Lansdorp P. M., Bonadonna G., Gianni A. M. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400–409
   PubMed Web of Science ®Google Scholar
• Fritsch G., Emminger W., Buchinger P., Printz D., Gadner H. CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp. Hematol. 1991; 19: 1079–1083
   PubMed Web of Science ®Google Scholar
• Beschorner W. E., Civin C. I., Strauss L. C. localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody. Am. J. Pathol. 1985; 119: 1–4
   PubMed Web of Science ®Google Scholar
• Fina L., Molgaard H. V., Robertson D., Bradley N. J., Monaghan P., Delia D., Sutherland D. R., Baker M. A., Greaves M. F. Expression of the CD34 gene in vascular endothelial cells. Blood 1990; 75: 2417–2426
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Shuster J. J., Civin C. I., Carroll A. J., Look A. T., Behm F. G., Land V. J., Pullen D. J., Crist W. M. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. J. Clin. Oncol. 1990; 8: 1389–1398
   PubMed Web of Science ®Google Scholar
• Thiel E., Kranz B. R., Raghavachar A., Bartram C. R., Loffler H., Messerer D., Ganser A., Ludwig W. D., Buchner T., Hoelzer D. Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 1989; 73: 1247–1258
   PubMed Web of Science ®Google Scholar
• Vaughan W. P., Civin C. I., Weisenburger D. D., Karp J. E., Graham M. L., Sanger W. G., Grierson H. L., Joshi S. S., Burke P. J. Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY 10). Leukemia 1988; 2: 661–666
   PubMed Web of Science ®Google Scholar
• Batinic D., Tindle R., Boban D., Tielenbach A., Rajic L., Labar B., Nemet D., Boranic M. Expression of haematopoietic progenitor cell-associated antigen B1–3C5/CD34 in leukemia. Leukemia Res. 1989; 13: 83–85
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Devaux Y., Treille D., Larese A., Maupas J., Gentilhomme O., Ehr-Sam A., Fiere D. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. Br. J. Haematol. 1989; 72: 161–166
   PubMed Web of Science ®Google Scholar
• San Miguel J. F., Gonzalez M., Canizo M. C., Anta J. P., Hernandez J., Ortega F., Lopez Borrasca A. The nature of blast cells in myelodysplastic syndromes evolving to acute leukaemia. Blut 1986; 52: 357–363
   PubMedGoogle Scholar
• Guyotat D., Campos L., Thomas X., Vila L., Shi Z.-H., Charrin C., Gentilhomme O., Fiere D. Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns. Am. J. Hematol. 1990; 34: 26–31
   PubMed Web of Science ®Google Scholar
• Katz F., Tindle R., Sutherland R., Greaves M. F. Identification of a membrane glycoprotein associated with haematopoietic progenitor cells. Leukemia Res. 1985; 9: 191–198
   PubMed Web of Science ®Google Scholar
• Andrew R. G., Singer J. W., Bernstein I. D. Monoclonal antibody 12–8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986; 67: 842–845
   PubMed Web of Science ®Google Scholar
• Watt S. M., Karhi K., Gatter K., Furley A. J. W., Katz F. E., Healy L. E., Attass L. J., Bradley N. J., Sutherland D. R., Levinsky R., Greaves M. F. Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells. Leukemia 1987; 1: 417–426
   PubMed Web of Science ®Google Scholar
• Sutherland D. R., Watt S. M., Dowden G., Karhi K., Baker M. A., Greaves M. F., Smart J. E. Structural and partial amino acid sequence analysis of the human hemopoietic progenitor antigen CD34. Leukemia 1989; 2: 793–803
   Web of Science ®Google Scholar
• Molgaard H. V., Spurr N. K., Greaves M. F. The hemopoietic stem cell antigen, CD34, is encoded by a gene located on chromosome 1. Leukemia 1989; 3: 773–776
   PubMed Web of Science ®Google Scholar
• Fackler M. J., Civin C. I., Sutherland D. R., Baker M. A., May W. S. Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells. J. Biologic. Chem. 1990; 265: 11056–11061
   PubMed Web of Science ®Google Scholar
• Fackler M. J., Civin C. I., May W. S. Upregulation of surface CD34 is associated with protein kinase C-mediatcd hyperphosphorylation of CD34. J. Biolog. Chem. 1992; 267: 17540–17546
   PubMed Web of Science ®Google Scholar
• Sutherland D. R., Fackler M. J., May W. S., Matthews K. E., Baker M. A. Activated protein kinase C directly phosphorylates the CD34 antigen in acute lymphoblastic leukemia cells. Leukemia & Lymphoma 1992; 8: 337–344
   PubMed Web of Science ®Google Scholar
• Spangrude G. J., Heimfeld S., Weissmann I. L. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241: 58–62
   PubMed Web of Science ®Google Scholar
• Ema H., Suda T., Miura Y., Nakauchi H. Colony formation 2 of clone-sorted human hematopoietic progenitors. Blood 1990; 75: 1941–1946
   PubMed Web of Science ®Google Scholar
• Civin C. I., Strauss L. C., Fackler M. J., Trischmann T. M., Wiley J. M., Loken M. R. Positive stem cell selection: Basic science. Bone Marrow Purging & Processing, R. Alan Liss, S. Gross, A. Gee, D. Worthing-White, 1990; 387–402
   Google Scholar
• Sawada K., Krantz S. B., Dai C. H., Koury S. T., Horn S. T., Click A. D., Civin C. I. Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J. Cell. Physiol. 1990; 142: 219–230
   PubMed Web of Science ®Google Scholar
• Sato N., Sawada K., Kannonji M., Tarumi T., Sakai N., Ieko M., Sakurama S., Nakagawa S., Yasukouchi T., Krantz S. B. Purification of human bone marrow progenitor cells and demonstration of the direct action of macrophage colony-stimulating factor on colony-forming unit-macrophage. Blood 1991; 78: 967–974
   PubMed Web of Science ®Google Scholar
• Hanamura T., Motoyoshi K., Yoshida K., Saito M., Miura Y., Kawashima T., Nishida M., Takaku F. Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood 1988; 72: 886–892
   PubMed Web of Science ®Google Scholar
• Jacobs A., Janowska-Wieczorek A., Cam J., Bowen D. T., Lewis T. Circulating erythropoietin in patients with myelodysplastic syndromes. Br. J. Haematol. 1989; 73: 36–39
   PubMed Web of Science ®Google Scholar
• Mempel K., Pietsch T., Menzel T., Zeidler C., Welte K. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 1991; 77: 1919–1922
   PubMed Web of Science ®Google Scholar
• Lefkovits I., Waldman H. Limiting dilution analysis of the cells of immune system. I. the clonal basis of the immune response. Immunologic. Today 1984; 5: 265–268
   PubMedGoogle Scholar
• Baines P., Masters G. S., Lush C., Jacobs A. Enrichment of haematopoietic progenitor cells from the marrow of patients with myelodysplasia. Br. J. Haematol. 1988; 68: 159–164
   PubMed Web of Science ®Google Scholar
• Iscove N. N., Guilbert L. J., Weyman C. Complete replacement of serum in primary cultures of erythropoietin-dependent red cell precursors (CFU-E) by albumin, transferrin, iron, unsaturated fatty acid, lecithin and cholesterol. Exp. Cell Res. 1980; 126: 121–126
   PubMed Web of Science ®Google Scholar
• Casadevall N., Vainchenker W., Lacombe C, Vinci G., Chapman J., Breton-Gorius J., Varet B. Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum free cultures. Blood 1982; 59: 447–451
   PubMed Web of Science ®Google Scholar
• Stewart S., Zhu B., Axelrad A. A “serum-free” medium for the production of erythropoietic bursts by murine bone marrow cells. Exp. Hemalol. 1984; 12: 309–318
   PubMed Web of Science ®Google Scholar
• Akahane K., Arinobu T., Urabe A., Takaku F. Pure erythropoietic colony and burst formations in serum-free culture and their enhancement by insulin-like growth factor I. Exp. Hematol. 1987; 15: 797–802
   PubMed Web of Science ®Google Scholar
• Negrin R. S., Haeuber D. H., Nagler A., Olds L. C., Donlon T., Souza L. M., Greenberg P. L. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor. A phase III trial. Ann. Intern. Med. 1989; 110: 976–984
   PubMed Web of Science ®Google Scholar
• Kobayashi Y., Okabe T., Ozawa K., Chiba S., Hino M., Miyazono K., Urabe A., Takaku F. Treatment of myelodysplastic syndromes with recombinant human granulocyte-colony stimulating factor: A preliminary report. Am. J. Med. 1989; 86: 178–182
   PubMed Web of Science ®Google Scholar
• Greenberg P., Negrin R., Nagler A., Vincent M., Donlon T. Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. Int. J. Cell Clon. 1990; (Suppl. 1): 293–302
   Google Scholar
• Yoshida Y., Hirashima K., Asano S., Takaku F. A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes. Br. J. Haematol. 1991; 78: 378–384
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj S., Keating M., Le Maistre A., Hittelman W. N., McCredie K., Trujillo J. M., Broxmeyer H. E., Hen-Ney C., Gutterman J. U. Effects of recombinant human granulocyte-macrophage colony stimulating factor in patients with myelodysplastic syndromes. N. Engl. J. Med. 1987; 317: 1545–1552
   PubMed Web of Science ®Google Scholar
• Antin J. H., Smith B. R., Holmes W., Rosenthal D. S. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 1988; 72: 705–713
   PubMed Web of Science ®Google Scholar
• Ganser A., Volkers B., Greher J., Ottmann O. G., Walther F., Becher R., Bergmann L., Schulz G., Hoelzer D. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes—A phase I/II trial. Blood 1989; 73: 31–37
   PubMed Web of Science ®Google Scholar
• Thompson J. A., Lee D. J., Kidd P., Rubin E., Kaufmann J., Bonnem E. M., Fefer A. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: Toxicity, pharmacokinetics, and hematologic effects. J. Clin. Oncol. 1989; 7: 629–637
   PubMed Web of Science ®Google Scholar
• Ganser A., Seipelt G., Lindemann A., Ottmann O. G., Falk S., Eder M., Herrmann F., Becher R., Hoffken K., Buchner T., Klausmann M., Frish J., Schulz G., Mer-Telsmann R., Hoelzer D. Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood 1990; 76: 455–462
   PubMed Web of Science ®Google Scholar
• Negrin R. S., Haeuber D. H., Nagler A., Kobayashi Y., Sklar J., Donlon T., Vincent M., Greenberg P. L. Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony stimulating factor. Blood 1990; 76: 36–43
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Talpaz M., Estrov Z., Rosenblum M. G., Gutterman J. U. Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. J. Clin. Oncol. 1991; 9: 1241–1250
   PubMed Web of Science ®Google Scholar
• Greenberg P. L. In-vitro culture techniques defining biologic abnormalities in the myelodysplasia syndromes and myeloproliferative disorders. Clin. Haematol. 1986; 15: 973–993
   PubMedGoogle Scholar
• Nagler A., Binet C., Mackichan M. L., Negrin R., Bangs C., Donlon T., Greenberg P. Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: Comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF. Blood 1990a; 76: 1299–1370
   PubMed Web of Science ®Google Scholar
• Nagler A., Ginzton N., Negrin R., Bang D., Donlon T., Greenberg P. Effects of recombinant human granulocyte colony stimulating factor and granulocytemonocyte colony stimulating factor on in vitro hematopoiesis in the myelodysplastic syndromes. Leukemia 1990b; 4: 193–202
   PubMed Web of Science ®Google Scholar
• Golde D. W., Cline M. J. Human preleukemia: Identification of a maturation defect in vitro. N. Engl. J. Med. 1973; 288: 1083–1086
   PubMed Web of Science ®Google Scholar
• Firkin F. C., Birner R., Russell S. H., Garson M. Contrasting patterns of neoplastic cell behaviour in long-term culture of bone marrow from patients with acute leukaemia and myelodysplastic disorders. Br. J. Haematol. 1990; 75: 476–484
   PubMed Web of Science ®Google Scholar
• Schipperus M., Sonneveld P., Lindemans J., Hagemeijer A., Vink N., Pegels J., Abels J. The effects of interleukin-3, GM-CSF, and G-CSF on the growth kinetics of colony-forming cells in myelodysplastic syndromes. Leukemia 1990; 4: 267–272
   PubMed Web of Science ®Google Scholar
• Merchav S., Wagemarker G., Souza L. M., Tatarsky I. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant hematopoietic growth factors. Leukemia 1991; 5: 340–346
   PubMed Web of Science ®Google Scholar
• Mayani H., Baines P., Bowen D. T., Jacobs A. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia 1989; 3: 29–32
   PubMed Web of Science ®Google Scholar
• Backx B., Breeders L., Touw I., Lowenberg B. Blast colony-forming cells in myelodysplastic syndrome: Decreased potential to generate erythroid precursors. Leukemia 1993; 7: 75–79
   PubMed Web of Science ®Google Scholar
• Greenberg P. L., Mara B., Bax I., Brossel R., Schrier S. The myeloproliferative disorders: Correlation between clinical evolution and alteration of granulopoiesis. Am. J. Med. 1976; 61: 878–891
   PubMed Web of Science ®Google Scholar
• Faille A., Dresch C., Poirer O., Balitrand N., Najean Y. Prognostic value of in vitro bone marrow culture in refractory anaemia with excess of myeloblasts. Scand. J. Haematol. 1978; 20: 280–286
   PubMedGoogle Scholar
• Berthier R., Douady F., Metral J., Newton I., Schweitzer A., Holland D. In vitro granulopoiesis in oligoblastic leukemia: Prognostic value, characterization and serial cloning of bone marrow colony and cluster forming cells in agar culture. Biomedicine 1979; 30: 305–311
   PubMedGoogle Scholar
• Spitzer G., Verma D. S., Dicke K. A., Smith T., McCredie K. B. Subgroups of oligoleukemia as identified by in vitro agar culture. Leukemia Res. 1979; 3: 29–39
   PubMed Web of Science ®Google Scholar
• Verma D. S., Spitzer G., Dicke K. A., McCredie K. B. In vitro agar culture patterns in preleukemia and their clinical significance. Leukemia Res. 1979; 3: 41–49
   PubMed Web of Science ®Google Scholar
• Karsdorf A., Dresh C., Metral J., Najean Y. Prognostic value of the combined suicide level of granulocyte progenitors and the labelling index of precursors in preleukemic states and oligoblastic leukemias. Leukemia Res. 1983; 7: 279–286
   PubMed Web of Science ®Google Scholar
• Raymakers R., De Witte T., Joziasse J., Van Der Lely N., Boezeman J., Haanen C. In vitro growth pattern and differentiation predict for progression of myelodysplastic syndromes to acute nonlymphocytic leukaemia. Br. J. Haematol. 1991; 78: 35–41
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Young D., Herrmann F., Wiper D., Wagner K., Sabbath K. D. Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblasts leukemia. Blood 1986; 67: 1448–1453
   PubMed Web of Science ®Google Scholar
• Miyauchi J., Kelleher C. A., Yang Yu.-C., Wong G. G., Clark C. C., Minden M. D., Minkin S., McCulloch. The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast ceils of acute myeloblasts leukemia maintained in short-term suspension culture. Blood 1987; 70: 657–663
   PubMed Web of Science ®Google Scholar
• Delwel R., Salem M., Pellens C., Dorssers L., Wagemaker G., Clark S., Lowenberg B. Growth regulation of human acute myeloid leukemia: Effects of five recombinant hematopoietic factors in a serum-free culture system. Blood 1988; 72: 1944–1949
   PubMed Web of Science ®Google Scholar
• Pebusque M.-J., Lopez M., Torres H., Carotti A., Guilbert L., Mannoni P. Growth response of human myeloid leukemia cells to colony-stimulating factors. Exp. Hematol. 1988; 16: 360–366
   PubMed Web of Science ®Google Scholar
• Salem M., Delwel R., Mahmoud L. A., Clark S., Elbasousy E. M., Lowenberg B. Maturation of human acute myeloid leukemia in vitro: the response to five recombinant hematopoietic factors in a serum-free system. Br. J. Haematol. 1989; 71: 363–370
   PubMed Web of Science ®Google Scholar
• Masuya M., Kita K., Shimuzu N., Onishi K., Kitayama N., Sekine T., Otsuji A., Miwa H., Shirakawa S. Biologic characteristics of acute leukemia after myelodysplastic syndrome. Blood 1993; 81: 3388–3394
   PubMed Web of Science ®Google Scholar
• Hokland P., Kerndrup G., Griffin J. D., Ellegaard J. Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. Blood 1986; 67: 898–902
   PubMed Web of Science ®Google Scholar
• Kerndrup G., Bendix-Hansen K., Pedersen B., Ellegaard J., Hokland P. Analysis of leukocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia (RA) and RA with sideroblasts. Prognostic indications of sequential and follow-up data. Eur. J. Haematol. 1988; 41: 368–374
   PubMed Web of Science ®Google Scholar
• Kristensen J. S., Hokland P. Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes. Br. J. Haematol. 1990; 74: 270–276
   PubMed Web of Science ®Google Scholar
• Thomas X., Guyotat D., Campos L., Shi Z. H., Vila L., Ehrsam A., Fiere D. In vitro effects of recombinant hemopoietic growth factors on progenitor cells from patients with myelodysplastic syndromes. Leukemia Res. 1991; 15: 29–36
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Davis R., Nelson D. A., Davey F. R., Mayer R. J., Schiffer C., McLntyre O. R., Bloomfield C. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood 1986; 68: 1232–1241
   PubMed Web of Science ®Google Scholar
• Clark R. E., Hoy T. G., Jacobs A. granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes. J. Clin. Pathol. 1985; 38: 301–304
   PubMed Web of Science ®Google Scholar
• Clark R. E., Smith S. A., Jacobs A. Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid. J. Clin. Pathol., 40: 652–656
   PubMed Web of Science ®Google Scholar
• San Miguel J. F., Hernandez J. M., Gonzalez-Sarmiento R., Gonzalez M., Sanchez I., Orfao A., Canizo M. C., Borrasca A. L. Acute leukemia after a primary myelodysplastic syndrome: Immunophenotypic, genotypic, and clinical characteristics. Blood 1991; 78: 768–774
   PubMed Web of Science ®Google Scholar
• Sullivan S. A., Marsden K. A., Lowenthal R. M., Jupe D. M., Jones M. E. Circulating CD34+ cells: an adverse prognostic factor in the myelodysplastic syn dromes. Am. J. Hematol. 1992; 39: 96–101
   PubMed Web of Science ®Google Scholar
• List A. F., Spier C. M., Cline A., Doll D. C., Garewal H., Morgan R., Sandberg A. A. Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype. Br. J. Haematol. 1991; 78: 28–34
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Calmard-Oriol P., Tsuruo T., Troncy J., Treille D., Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79: 473–476
   PubMed Web of Science ®Google Scholar
• Kibbelaar R. E., van Kamp H., Dreef E. J., de Groot-Swings G., Kluin-Nelemans J. C, Beverstock G. C., Fibbe W. E., Kluin P. M. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplasia syndromes. Blood 1992; 79: 1823–1828
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Boot A. J., Mayer M. G., Bos J. L. Mechanisms of ras mutation in myelodysplastic syndrome. Oncogene. 1989; 4: 609–614
   PubMed Web of Science ®Google Scholar
• Padua R. A., Carter G., Hughes D., Gow J., Farr C., Oscier D., McCormick F., Jacobs A. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization and transformation. Leukemia 1988; 2: 503–510
   PubMed Web of Science ®Google Scholar
• Liu E., Hjelle B., Morgan R., Hecht F., Bishop J. M. Mutation of the Kirsten-ras proto-oncogene in human preleukemia. Nature 1987; 330: 186–188
   PubMed Web of Science ®Google Scholar
• Gregory C. J., Henkelman R. M. Relationship between early hemopoietic progenitor cells determined by correlation analysis of their numbers in individual spleen colonies. Experimental Hematology Today, S. J. Baum, B. D. Ledney. Springer-Verlag, New York 1977; 93–101
   Google Scholar
• Sawada K., Krantz S. B., Dai C. H., Sato N., Ieko M., Sakurama S., Yasukouchi T., Nakagawa S. Transitional change of colony stimulating factor requirements for erythroid progenitors. J. Cell. Physiol. 1991; 149: 1–8
   PubMed Web of Science ®Google Scholar
• Schouten H. C., Delwel R., Bot F. J., Hagemeijer A., Touw I. P., Lowenberg B. Characterization of clonogenic cells in refractory anemia with excess, of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes. Leukemia Res. 1989; 13: 245–251
   PubMed Web of Science ®Google Scholar
• Campos L., Ffrench M., Guyotat D. Myeloid differentiation antigens identify leukemic cell subpopulations with different cell cycle characteristics. Leukemia 1990; 4: 60–62
   PubMed Web of Science ®Google Scholar